等待开盘 01-15 09:30:00 美东时间
-0.300
-4.74%
Gainers X3 Holdings (NASDAQ:XTKG) stock rose 10.9% to $0.18 during Tuesday's a...
2025-12-24 05:05
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46
HC Wainwright & Co. analyst Scott Buck maintains Intellicheck (NASDAQ:IDN) with a Buy and raises the price target from $6 to $8.5.
2025-12-16 20:06
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
2025-11-25 10:27
DA Davidson analyst Rudy Kessinger maintains Intellicheck (NASDAQ:IDN) with a Neutral and maintains $7.5 price target.
2025-11-25 02:12
In the world of technology stocks, growth is the name of the game. This week, f...
2025-11-18 23:44
美国火箭制造商FLY涨17%,Q3业绩超预期且中标多项合同;希悦尔涨近17%,与私募公司就私有化进行谈判>>
2025-11-14 18:48
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
DA Davidson analyst Rudy Kessinger maintains Intellicheck (NASDAQ:IDN) with a Neutral and raises the price target from $6.5 to $7.5.
2025-11-13 22:48
Gainers Cellebrite DI (NASDAQ:CLBT) stock moved upwards by 18.1% to $18.87 dur...
2025-11-13 20:05